New Collaborative Study Uses Pangea’s Platform to Create World’s First Sequencing-Free, Transcriptomics-Based Drug Response Predicting System

Published in bioRxiv, the study leverages Pangea Biomed’s ENLIGHT platform to develop a novel approach to precision cancer care that combines AI techniques and digital pathology, bypassing the need for expensive and time-consuming DNA and RNA sequencing